ATMOS, A Proof-of-Concept Trial of Inhaled Mosliciguat, A First-in-Class Soluble Guanylate Cyclase Activator-A Novel Approach to Address Unmet Needs in PH

Ghofrani, H. A. and Leuchte, H. and Al Hiti, H. and Halank, M. and Jansa, P. and Lange, Tobias J. and Olschewski, H. and Tello, K. and Becker, E. and Ligges, S. and Nagelschmitz, J. and Nikkho, S. M. and Penugonda, S. and Saleh, S. and Vesterinen, P. and Woischnik, M. and Jung, D. and Kopec, G. (2025) ATMOS, A Proof-of-Concept Trial of Inhaled Mosliciguat, A First-in-Class Soluble Guanylate Cyclase Activator-A Novel Approach to Address Unmet Needs in PH. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 211 (Suppl1): A4978. ISSN 1073-449X, 1535-4970

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin II
Depositing User: Dr. Gernot Deinzer
Date Deposited: 04 Nov 2026 05:44
Last Modified: 04 Nov 2026 05:44
URI: https://pred.uni-regensburg.de/id/eprint/67358

Actions (login required)

View Item View Item